Skip to content
← Back to this collection

PUBLICATIONS · 20018913

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2010 Mar 4
First author
Adès L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Adès L
      type
      Author
    2. name
      Guerci A
      type
      Author
    3. name
      Raffoux E
      type
      Author
    4. name
      Sanz M
      type
      Author
    5. name
      Chevallier P
      type
      Author
    6. name
      Lapusan S
      type
      Author
    7. name
      Recher C
      type
      Author
    8. name
      Thomas X
      type
      Author
    9. name
      Rayon C
      type
      Author
    10. name
      Castaigne S
      type
      Author
    11. name
      Tournilhac O
      type
      Author
    12. name
      de Botton S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Adès L
      type
      Author
    2. name
      Guerci A
      type
      Author
    3. name
      Raffoux E
      type
      Author
    4. name
      Sanz M
      type
      Author
    5. name
      Chevallier P
      type
      Author
    6. name
      Lapusan S
      type
      Author
    7. name
      Recher C
      type
      Author
    8. name
      Thomas X
      type
      Author
    9. name
      Rayon C
      type
      Author
    10. name
      Castaigne S
      type
      Author
    11. name
      Tournilhac O
      type
      Author
    12. name
      de Botton S
      type
      Author
    bibliography ids
    1. nci-bib-28942ee8d605a51fe954d1e4
    book metadata
    content sha256
    b0fd87ef6d1a125a2eca0d0ff214a8669904e040f3d107e1f7fae470ccc5fba3
    document type
    citation
    dois
    1. 10.1182/blood-2009-07-233387
    electronic publication date
    display
    2009 Dec 17
    precision
    day
    year
    2009
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20018913
    immutable id
    pubmed:20018913@b0fd87ef6d1a125a2eca0d0ff214a8669904e040f3d107e1f7fae470ccc5fba3
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    9
    name
    Blood
    nlm unique id
    7603509
    pages
    1690-6
    volume
    115
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20018913
      provenance
      batch id
      708c7929ee1eff455330
      provider
      NCBI PubMed ESummary
      record sha256
      18dcab88d4aafdc491050829324b3886d96373481d066360526f23c6c42d1d46
      response sha256
      d245af3dbc636ffc79325b3798c7bfda16faf0a3d796681b12b8d89bd68eb450
      retrieved at
      2026-09-09T23:46:31.496840+00:00
      publication date
      display
      2010 Mar 4
      precision
      day
      year
      2010
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20018913/
      title
      Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.

      Preserved source evidence · Not medical advice